President and COO · Adaptive Biotechnologies Corp · Adaptive Biotechnologies Corp — Stock Option (right to buy)
Side
M
Value
—
Shares
14.7K
Price
—
Executed
Apr 21, 2026
Disclosed
Apr 21, 2026
Disclosure timeline0 days from execution to publication · legal deadline 2 business days
Apr 21 executedApr 21, 2026 disclosed
ADPT · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Option exercise — administrative, little informational value
Relative size+5 / 25
No reported dollar value · 16.4% of prior position
Filing timing0 / 15
Disclosed 0 business days after execution (deadline: 2)
Historical behavior+1 / 15
Routine: 22 prior trades recorded in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Adaptive Biotechnologies Corp — Stock Option (right to buy)
Ticker
ADPT
Shares
14.7K
Price per share
$0
Execution date (reported)
Apr 21, 2026
Owned after transaction
104.6K shares
Rule 10b5-1 plan
Yes, as checked by the filer
Days from execution to publication
0
What this establishes
Rubinstein Julie filed this Form 4 reporting a option exercise of ADPT on Apr 21, 2026. It became public on Apr 21, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
President and COO
Rubinstein Juliecik:0001780664
Issuer
Adaptive Biotechnologies Corpcik:0001478320
Revision history · 0
No field has changed since this record was first ingested.
